Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 23 of 23 entries
Sorted by: Best Match Show Resources per page
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions.

Clinical endocrinology

Tanda ML, Lai A, Bartalena L.
PMID: 18785990
Clin Endocrinol (Oxf). 2008 Dec;69(6):845-7. doi: 10.1111/j.1365-2265.2008.03417.x. Epub 2008 Sep 10.

No abstract available.

Cite
Tanda ML, Lai A, Bartalena L. Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions. Clin Endocrinol (Oxf). 2008;69(6):845-7doi: 10.1111/j.1365-2265.2008.03417.x.
Tanda, M. L., Lai, A., & Bartalena, L. (2008). Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions. Clinical endocrinology, 69(6), 845-7. https://doi.org/10.1111/j.1365-2265.2008.03417.x
Tanda, Maria Laura, et al. "Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions." Clinical endocrinology vol. 69,6 (2008): 845-7. doi: https://doi.org/10.1111/j.1365-2265.2008.03417.x
Tanda ML, Lai A, Bartalena L. Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions. Clin Endocrinol (Oxf). 2008 Dec;69(6):845-7. doi: 10.1111/j.1365-2265.2008.03417.x. Epub 2008 Sep 10. PMID: 18785990.
Copy Download .nbib Format: NLM
Predicting radiotherapy-related clinical toxicities in cancer: a literature review.

Clinical journal of oncology nursing

O'Gorman C, Sasiadek W, Denieffe S, Gooney M.
PMID: 24867122
Clin J Oncol Nurs. 2014 Jun;18(3):E37-44. doi: 10.1188/14.CJON.E37-E44.

Assessment of patients receiving radiotherapy for cancer is essential, with the ability to identify those who may be more likely to experience radiotherapy-related side effects noted as an important issue for nurses. Body mass, age, and radiation dose may...

Cite
O'Gorman C, Sasiadek W, Denieffe S, et al. Predicting radiotherapy-related clinical toxicities in cancer: a literature review. Clin J Oncol Nurs. 2014;18(3):E37-44doi: 10.1188/14.CJON.E37-E44.
O'Gorman, C., Sasiadek, W., Denieffe, S., & Gooney, M. (2014). Predicting radiotherapy-related clinical toxicities in cancer: a literature review. Clinical journal of oncology nursing, 18(3), E37-44. https://doi.org/10.1188/14.CJON.E37-E44
O'Gorman, Claire, et al. "Predicting radiotherapy-related clinical toxicities in cancer: a literature review." Clinical journal of oncology nursing vol. 18,3 (2014): E37-44. doi: https://doi.org/10.1188/14.CJON.E37-E44
O'Gorman C, Sasiadek W, Denieffe S, Gooney M. Predicting radiotherapy-related clinical toxicities in cancer: a literature review. Clin J Oncol Nurs. 2014 Jun;18(3):E37-44. doi: 10.1188/14.CJON.E37-E44. PMID: 24867122.
Copy Download .nbib Format: NLM
Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Purcell A, Fleming J, Bennett S, Burmeister B, Haines T.
PMID: 19468758
Support Care Cancer. 2010 Mar;18(3):307-15. doi: 10.1007/s00520-009-0653-z. Epub 2009 May 26.

PURPOSE: The Multidimensional Fatigue Inventory (MFI) is a commonly used cancer-related fatigue assessment tool. Unlike other fatigue assessments, there are no published minimal clinically important difference (MCID) criteria for the MFI in cancer populations. MCID criteria determine the smallest...

Cite
Purcell A, Fleming J, Bennett S, et al. Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer. 2009;18(3):307-15doi: 10.1007/s00520-009-0653-z.
Purcell, A., Fleming, J., Bennett, S., Burmeister, B., & Haines, T. (2010). Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 18(3), 307-15. https://doi.org/10.1007/s00520-009-0653-z
Purcell, Amanda, et al. "Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 18,3 (2010): 307-15. doi: https://doi.org/10.1007/s00520-009-0653-z
Purcell A, Fleming J, Bennett S, Burmeister B, Haines T. Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer. 2010 Mar;18(3):307-15. doi: 10.1007/s00520-009-0653-z. Epub 2009 May 26. PMID: 19468758.
Copy Download .nbib Format: NLM
Accelerated fractionation: what is the price for speeding?.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ang KK.
PMID: 9288837
Radiother Oncol. 1997 Aug;44(2):97-9. doi: 10.1016/s0167-8140(97)00117-5.

No abstract available.

Cite
Ang KK. Accelerated fractionation: what is the price for speeding?. Radiother Oncol. 1997;44(2):97-9doi: 10.1016/s0167-8140(97)00117-5.
Ang, K. K. (1997). Accelerated fractionation: what is the price for speeding?. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 44(2), 97-9. https://doi.org/10.1016/s0167-8140(97)00117-5
Ang, K K. "Accelerated fractionation: what is the price for speeding?." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 44,2 (1997): 97-9. doi: https://doi.org/10.1016/s0167-8140(97)00117-5
Ang KK. Accelerated fractionation: what is the price for speeding?. Radiother Oncol. 1997 Aug;44(2):97-9. doi: 10.1016/s0167-8140(97)00117-5. PMID: 9288837.
Copy Download .nbib Format: NLM
[Acute and late toxicities and its management].

Nihon rinsho. Japanese journal of clinical medicine

Asakawa I, Hasegawa M.
PMID: 22208018
Nihon Rinsho. 2011 Jun;69:435-9.

No abstract available.

Cite
Asakawa I, Hasegawa M. [Acute and late toxicities and its management]. Nihon Rinsho. 2011;69:435-9
Asakawa, I., & Hasegawa, M. (2011). [Acute and late toxicities and its management]. Nihon rinsho. Japanese journal of clinical medicine, 69435-9.
Asakawa, Isao, and Hasegawa, Masatoshi. "[Acute and late toxicities and its management]." Nihon rinsho. Japanese journal of clinical medicine vol. 69 (2011): 435-9.
Asakawa I, Hasegawa M. [Acute and late toxicities and its management]. Nihon Rinsho. 2011 Jun;69:435-9. Japanese. PMID: 22208018.
Copy Download .nbib Format: NLM
Radiation oncologists' response to pundendal entrapment neuropathy.

Pain physician

Pieters RS, Sirkis H, Aronowitz JN.
PMID: 24658494
Pain Physician. 2014 Mar-Apr;17(2):E237-8.

No abstract available.

Cite
Pieters RS, Sirkis H, Aronowitz JN. Radiation oncologists' response to pundendal entrapment neuropathy. Pain Physician. 2014;17(2):E237-8
Pieters, R. S., Sirkis, H., & Aronowitz, J. N. (2014). Radiation oncologists' response to pundendal entrapment neuropathy. Pain physician, 17(2), E237-8.
Pieters, Richard S, et al. "Radiation oncologists' response to pundendal entrapment neuropathy." Pain physician vol. 17,2 (2014): E237-8.
Pieters RS, Sirkis H, Aronowitz JN. Radiation oncologists' response to pundendal entrapment neuropathy. Pain Physician. 2014 Mar-Apr;17(2):E237-8. PMID: 24658494.
Copy Download .nbib Format: NLM
Evolving Radiotherapy Techniques in Paediatric Oncology.

Clinical oncology (Royal College of Radiologists (Great Britain))

Steinmeier T, Schulze Schleithoff S, Timmermann B.
PMID: 30639254
Clin Oncol (R Coll Radiol). 2019 Mar;31(3):142-150. doi: 10.1016/j.clon.2018.12.005. Epub 2019 Jan 11.

AIMS: Childhood cancer is rare and survival of childhood cancer has increased up to 80% at 5 years after diagnosis. Radiotherapy is an important element of the multimodal treatment concept. However, due to growing tissue, children are particularly sensitive...

Cite
Steinmeier T, Schulze Schleithoff S, Timmermann B. Evolving Radiotherapy Techniques in Paediatric Oncology. Clin Oncol (R Coll Radiol). 2019;31(3):142-150doi: 10.1016/j.clon.2018.12.005.
Steinmeier, T., Schulze Schleithoff, S., & Timmermann, B. (2019). Evolving Radiotherapy Techniques in Paediatric Oncology. Clinical oncology (Royal College of Radiologists (Great Britain)), 31(3), 142-150. https://doi.org/10.1016/j.clon.2018.12.005
Steinmeier, T, et al. "Evolving Radiotherapy Techniques in Paediatric Oncology." Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 31,3 (2019): 142-150. doi: https://doi.org/10.1016/j.clon.2018.12.005
Steinmeier T, Schulze Schleithoff S, Timmermann B. Evolving Radiotherapy Techniques in Paediatric Oncology. Clin Oncol (R Coll Radiol). 2019 Mar;31(3):142-150. doi: 10.1016/j.clon.2018.12.005. Epub 2019 Jan 11. PMID: 30639254.
Copy Download .nbib Format: NLM
Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation.

Parkinsonism & related disorders

Smilowska K, Bloem BR, Esselink RAJ, Chaudhuri KR, van Wamelen DJ.
PMID: 31955127
Parkinsonism Relat Disord. 2020 Feb;71:15-16. doi: 10.1016/j.parkreldis.2020.01.005. Epub 2020 Jan 11.

No abstract available.

Cite
Smilowska K, Bloem BR, Esselink RAJ, et al. Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation. Parkinsonism Relat Disord. 2020;71:15-16doi: 10.1016/j.parkreldis.2020.01.005.
Smilowska, K., Bloem, B. R., Esselink, R. A. J., Chaudhuri, K. R., & van Wamelen, D. J. (2020). Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation. Parkinsonism & related disorders, 7115-16. https://doi.org/10.1016/j.parkreldis.2020.01.005
Smilowska, Katarzyna, et al. "Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation." Parkinsonism & related disorders vol. 71 (2020): 15-16. doi: https://doi.org/10.1016/j.parkreldis.2020.01.005
Smilowska K, Bloem BR, Esselink RAJ, Chaudhuri KR, van Wamelen DJ. Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation. Parkinsonism Relat Disord. 2020 Feb;71:15-16. doi: 10.1016/j.parkreldis.2020.01.005. Epub 2020 Jan 11. PMID: 31955127.
Copy Download .nbib Format: NLM
Radiotherapy for cancer. Quality of life.

Acta oncologica (Stockholm, Sweden)

Fürst CJ.
PMID: 9154107
Acta Oncol. 1996;35:141-8. doi: 10.3109/02841869609101675.

This synthesis of the literature on the quality of life in relation to radiotherapy is based on 78 scientific articles, including 12 randomized studies, 25 prospective studies, and 20 retrospective studies. These studies involve 9884 patients. Radiotherapy is often...

Cite
Fürst CJ. Radiotherapy for cancer. Quality of life. Acta Oncol. 1996;35:141-8doi: 10.3109/02841869609101675.
Fürst, C. J. (1996). Radiotherapy for cancer. Quality of life. Acta oncologica (Stockholm, Sweden), 35141-8. https://doi.org/10.3109/02841869609101675
Fürst, C J. "Radiotherapy for cancer. Quality of life." Acta oncologica (Stockholm, Sweden) vol. 35 (1996): 141-8. doi: https://doi.org/10.3109/02841869609101675
Fürst CJ. Radiotherapy for cancer. Quality of life. Acta Oncol. 1996;35:141-8. doi: 10.3109/02841869609101675. PMID: 9154107.
Copy Download .nbib Format: NLM
To prescribe or not to prescribe? Perceptions of radiation therapists prescribing medications for common radiation therapy side effects.

Journal of medical imaging and radiation sciences

Zokvic A, Farrell T, Quan K, Ho E, Smoke M.
PMID: 34610887
J Med Imaging Radiat Sci. 2021 Dec;52(4):552-558. doi: 10.1016/j.jmir.2021.09.003. Epub 2021 Oct 02.

BACKGROUND: During radiation therapy treatments patients may require medications to manage radiation toxicities. Since patients are assessed daily by Radiation Therapists (RTs) it would be optimal and timely for patients to receive medication prescriptions for relief of common radiation...

Cite
Zokvic A, Farrell T, Quan K, et al. To prescribe or not to prescribe? Perceptions of radiation therapists prescribing medications for common radiation therapy side effects. J Med Imaging Radiat Sci. 2021;52(4):552-558doi: 10.1016/j.jmir.2021.09.003.
Zokvic, A., Farrell, T., Quan, K., Ho, E., & Smoke, M. (2021). To prescribe or not to prescribe? Perceptions of radiation therapists prescribing medications for common radiation therapy side effects. Journal of medical imaging and radiation sciences, 52(4), 552-558. https://doi.org/10.1016/j.jmir.2021.09.003
Zokvic, Alyssa, et al. "To prescribe or not to prescribe? Perceptions of radiation therapists prescribing medications for common radiation therapy side effects." Journal of medical imaging and radiation sciences vol. 52,4 (2021): 552-558. doi: https://doi.org/10.1016/j.jmir.2021.09.003
Zokvic A, Farrell T, Quan K, Ho E, Smoke M. To prescribe or not to prescribe? Perceptions of radiation therapists prescribing medications for common radiation therapy side effects. J Med Imaging Radiat Sci. 2021 Dec;52(4):552-558. doi: 10.1016/j.jmir.2021.09.003. Epub 2021 Oct 02. PMID: 34610887.
Copy Download .nbib Format: NLM
We have met the Enemy and (S)He is Us.

Head & neck

Beitler JJ.
PMID: 33998092
Head Neck. 2021 Sep;43(9):2685-2687. doi: 10.1002/hed.26737. Epub 2021 May 17.

No abstract available.

Cite
Beitler JJ. We have met the Enemy and (S)He is Us. Head Neck. 2021;43(9):2685-2687doi: 10.1002/hed.26737.
Beitler, J. J. (2021). We have met the Enemy and (S)He is Us. Head & neck, 43(9), 2685-2687. https://doi.org/10.1002/hed.26737
Beitler, Jonathan J. "We have met the Enemy and (S)He is Us." Head & neck vol. 43,9 (2021): 2685-2687. doi: https://doi.org/10.1002/hed.26737
Beitler JJ. We have met the Enemy and (S)He is Us. Head Neck. 2021 Sep;43(9):2685-2687. doi: 10.1002/hed.26737. Epub 2021 May 17. PMID: 33998092.
Copy Download .nbib Format: NLM
Showing 13 to 23 of 23 entries